000 | 01109 a2200289 4500 | ||
---|---|---|---|
005 | 20250514230956.0 | ||
264 | 0 | _c20060414 | |
008 | 200604s 0 0 eng d | ||
022 | _a1744-7623 | ||
024 | 7 |
_a10.1517/14728214.10.2.403 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVerheul, Henk M W | |
245 | 0 | 0 |
_aInhibition of angiogenesis in cancer patients. _h[electronic resource] |
260 |
_bExpert opinion on emerging drugs _cMay 2005 |
||
300 |
_a403-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
650 | 0 | 4 |
_aDrugs, Investigational _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
700 | 1 | _aPinedo, Herbert M | |
773 | 0 |
_tExpert opinion on emerging drugs _gvol. 10 _gno. 2 _gp. 403-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728214.10.2.403 _zAvailable from publisher's website |
999 |
_c15595296 _d15595296 |